143 related articles for article (PubMed ID: 8542599)
1. 2-Nitroimidazole (EF5) binding predicts radiation resistance in individual 9L s.c. tumors.
Evans SM; Jenkins WT; Joiner B; Lord EM; Koch CJ
Cancer Res; 1996 Jan; 56(2):405-11. PubMed ID: 8542599
[TBL] [Abstract][Full Text] [Related]
2. Immunocytochemical labelling of aerobic and hypoxic mammalian cells using a platinated derivative of EF5.
Matthews J; Adomat H; Farrell N; King P; Koch C; Lord E; Palcic B; Poulin N; Sangulin J; Skov K
Br J Cancer Suppl; 1996 Jul; 27():S200-3. PubMed ID: 8763880
[TBL] [Abstract][Full Text] [Related]
3. Identification of hypoxia in cells and tissues of epigastric 9L rat glioma using EF5 [2-(2-nitro-1H-imidazol-1-yl)-N-(2,2,3,3,3-pentafluoropropyl) acetamide].
Evans SM; Joiner B; Jenkins WT; Laughlin KM; Lord EM; Koch CJ
Br J Cancer; 1995 Oct; 72(4):875-82. PubMed ID: 7547234
[TBL] [Abstract][Full Text] [Related]
4. Direct relationship between radiobiological hypoxia in tumors and monoclonal antibody detection of EF5 cellular adducts.
Lee J; Siemann DW; Koch CJ; Lord EM
Int J Cancer; 1996 Jul; 67(3):372-8. PubMed ID: 8707411
[TBL] [Abstract][Full Text] [Related]
5. Detection of hypoxic cells by monoclonal antibody recognizing 2-nitroimidazole adducts.
Lord EM; Harwell L; Koch CJ
Cancer Res; 1993 Dec; 53(23):5721-6. PubMed ID: 8242628
[TBL] [Abstract][Full Text] [Related]
6. EF5 binding and clinical outcome in human soft tissue sarcomas.
Evans SM; Fraker D; Hahn SM; Gleason K; Jenkins WT; Jenkins K; Hwang WT; Zhang P; Mick R; Koch CJ
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(3):922-7. PubMed ID: 16458778
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the concept of "hypoxic fraction" as a descriptor of tumor oxygenation status.
Evans SM; Jenkins WT; Shapiro M; Koch CJ
Adv Exp Med Biol; 1997; 411():215-25. PubMed ID: 9269430
[TBL] [Abstract][Full Text] [Related]
8. Detection of hypoxia in human squamous cell carcinoma by EF5 binding.
Evans SM; Hahn S; Pook DR; Jenkins WT; Chalian AA; Zhang P; Stevens C; Weber R; Weinstein G; Benjamin I; Mirza N; Morgan M; Rubin S; McKenna WG; Lord EM; Koch CJ
Cancer Res; 2000 Apr; 60(7):2018-24. PubMed ID: 10766193
[TBL] [Abstract][Full Text] [Related]
9. Detection of individual hypoxic cells in multicellular spheroids by flow cytometry using the 2-nitroimidazole, EF5, and monoclonal antibodies.
Woods ML; Koch CJ; Lord EM
Int J Radiat Oncol Biol Phys; 1996 Jan; 34(1):93-101. PubMed ID: 12118570
[TBL] [Abstract][Full Text] [Related]
10. Importance of antibody concentration in the assessment of cellular hypoxia by flow cytometry: EF5 and pimonidazole.
Koch CJ
Radiat Res; 2008 Jun; 169(6):677-88. PubMed ID: 18494550
[TBL] [Abstract][Full Text] [Related]
11. Hypoxia and necrosis in rat 9L glioma and Morris 7777 hepatoma tumors: comparative measurements using EF5 binding and the Eppendorf needle electrode.
Jenkins WT; Evans SM; Koch CJ
Int J Radiat Oncol Biol Phys; 2000 Mar; 46(4):1005-17. PubMed ID: 10705024
[TBL] [Abstract][Full Text] [Related]
12. Hypoxia in human intraperitoneal and extremity sarcomas.
Evans SM; Hahn SM; Magarelli DP; Zhang PJ; Jenkins WT; Fraker DL; Hsi RA; McKenna WG; Koch CJ
Int J Radiat Oncol Biol Phys; 2001 Feb; 49(2):587-96. PubMed ID: 11173159
[TBL] [Abstract][Full Text] [Related]
13. Hypoxia-inducible factor-1alpha is an intrinsic marker for hypoxia in cervical cancer xenografts.
Vukovic V; Haugland HK; Nicklee T; Morrison AJ; Hedley DW
Cancer Res; 2001 Oct; 61(20):7394-8. PubMed ID: 11606368
[TBL] [Abstract][Full Text] [Related]
14. Noninvasive imaging of tumor hypoxia in rats using the 2-nitroimidazole 18F-EF5.
Ziemer LS; Evans SM; Kachur AV; Shuman AL; Cardi CA; Jenkins WT; Karp JS; Alavi A; Dolbier WR; Koch CJ
Eur J Nucl Med Mol Imaging; 2003 Feb; 30(2):259-66. PubMed ID: 12552344
[TBL] [Abstract][Full Text] [Related]
15. Oxygen dependence of cellular uptake of EF5 [2-(2-nitro-1H-imidazol-1-yl)-N-(2,2,3,3,3-pentafluoropropyl)a cet amide] : analysis of drug adducts by fluorescent antibodies vs bound radioactivity.
Koch CJ; Evans SM; Lord EM
Br J Cancer; 1995 Oct; 72(4):869-74. PubMed ID: 7547233
[TBL] [Abstract][Full Text] [Related]
16. Tirapazamine-induced cytotoxicity and DNA damage in transplanted tumors: relationship to tumor hypoxia.
Siim BG; Menke DR; Dorie MJ; Brown JM
Cancer Res; 1997 Jul; 57(14):2922-8. PubMed ID: 9230202
[TBL] [Abstract][Full Text] [Related]
17. HER-2/neu overexpression increases the viable hypoxic cell population within solid tumors without causing changes in tumor vascularization.
Dragowska WH; Warburton C; Yapp DT; Minchinton AI; Hu Y; Waterhouse DN; Gelmon K; Skov K; Woo J; Masin D; Huxham LA; Kyle AH; Bally MB
Mol Cancer Res; 2004 Nov; 2(11):606-19. PubMed ID: 15561777
[TBL] [Abstract][Full Text] [Related]
18. Hypoxia in radiation-induced blood-spinal cord barrier breakdown.
Li YQ; Ballinger JR; Nordal RA; Su ZF; Wong CS
Cancer Res; 2001 Apr; 61(8):3348-54. PubMed ID: 11309291
[TBL] [Abstract][Full Text] [Related]
19. Distribution of misonidazole adducts in 9L gliosarcoma tumors and spheroids: implications for oxygen distribution.
Franko AJ; Koch CJ; Boisvert DP
Cancer Res; 1992 Jul; 52(14):3831-7. PubMed ID: 1617656
[TBL] [Abstract][Full Text] [Related]
20.
Qian Y; Von Eyben R; Liu Y; Chin FT; Miao Z; Apte S; Carter JN; Binkley MS; Pollom EL; Harris JP; Prionas ND; Kissel M; Simmons A; Diehn M; Shultz DB; Brown JM; Maxim PG; Koong AC; Graves EE; Loo BW
Int J Radiat Oncol Biol Phys; 2018 Nov; 102(4):1183-1192. PubMed ID: 29859786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
